Phytocannabinoids and psychiatry: what evidence?
DOI:
https://doi.org/10.25118/issn.2965-1832.2022.523Keywords:
phytocannabinoids, psychiatry, cannabinoids, cannabidiolAbstract
The possible effectiveness of cannabinoids has been the subject of several studies carried out around the world. Currently, the Federal Council of Medicine - CFM authorizes the compassionate use of cannabidiol only for cases of children and adolescents with difficult-to-treat epilepsy, that is, cases in which conventional options do not work. With this, many doubts began to arise on social networks and in the traditional media on the subject. After all, is there scientific evidence in prescribing cannabidiol for the treatment of psychiatric illnesses? Today, ABP TV will be dedicated to debating this much needed topic.

Downloads
Published
How to Cite
Conference Proceedings Volume
Section
Categories
License
Copyright (c) 2022 Fábio Barbirato, Gustavo Xavier de Azevedo Fernandes, Marcelo Allevato, Ronaldo Ramos Laranjeira

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.